loading
전일 마감가:
$1.74
열려 있는:
$1.75
하루 거래량:
279.66K
Relative Volume:
0.21
시가총액:
$285.02M
수익:
-
순이익/손실:
$-274.18M
주가수익비율:
-0.6944
EPS:
-2.5346
순현금흐름:
$-198.33M
1주 성능:
+9.32%
1개월 성능:
-25.11%
6개월 성능:
+13.55%
1년 성능:
-84.78%
1일 변동 폭
Value
$1.71
$1.795
1주일 범위
Value
$1.5706
$1.795
52주 변동 폭
Value
$0.611
$17.19

Neumora Therapeutics Inc Stock (NMRA) Company Profile

Name
명칭
Neumora Therapeutics Inc
Name
전화
(857) 760-0900
Name
주소
260 ARSENAL PLACE, SUITE 1, WATERTOWN
Name
직원
96
Name
트위터
Name
다음 수익 날짜
2025-03-03
Name
최신 SEC 제출 서류
Name
NMRA's Discussions on Twitter

NMRA을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
NMRA
Neumora Therapeutics Inc
1.76 281.79M 0 -274.18M -198.33M -2.5346
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
389.08 99.27B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
586.96 62.28B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
454.18 59.14B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
707.96 43.34B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
300.14 36.72B 3.81B -644.79M -669.77M -6.24

Neumora Therapeutics Inc Stock (NMRA) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-04-02 다운그레이드 BofA Securities Buy → Underperform
2025-03-10 다운그레이드 William Blair Outperform → Mkt Perform
2025-03-07 다운그레이드 Guggenheim Buy → Neutral
2025-03-07 다운그레이드 Stifel Buy → Hold
2025-01-02 다운그레이드 RBC Capital Mkts Outperform → Sector Perform
2024-11-05 다운그레이드 JP Morgan Overweight → Neutral
2024-10-01 개시 H.C. Wainwright Buy
2024-07-22 개시 Needham Buy
2024-07-08 개시 Mizuho Outperform
2023-12-12 개시 Deutsche Bank Hold
2023-10-10 개시 BofA Securities Buy
2023-10-10 개시 Guggenheim Buy
2023-10-10 개시 JP Morgan Overweight
2023-10-10 개시 RBC Capital Mkts Outperform
2023-10-10 개시 Stifel Buy
2023-10-10 개시 William Blair Outperform
모두보기

Neumora Therapeutics Inc 주식(NMRA)의 최신 뉴스

pulisher
02:09 AM

Why Neumora Therapeutics Inc. is moving todayPortfolio Growth Summary & High Conviction Buy Zone Picks - Newser

02:09 AM
pulisher
Aug 27, 2025

How to forecast Neumora Therapeutics Inc. trends using time seriesWeekly Market Report & Low Risk Entry Point Guides - Newser

Aug 27, 2025
pulisher
Aug 27, 2025

Neumora Therapeutics Inc. stock prediction for this weekInsider Selling & Weekly High Return Stock Opportunities - Newser

Aug 27, 2025
pulisher
Aug 27, 2025

Is Neumora Therapeutics Inc. a candidate for recovery playMarket Risk Report & Reliable Price Breakout Signals - Newser

Aug 27, 2025
pulisher
Aug 27, 2025

What’s the recovery path for long term holders of Neumora Therapeutics Inc.July 2025 Big Picture & Real-Time Volume Analysis Alerts - Newser

Aug 27, 2025
pulisher
Aug 27, 2025

Using economic indicators to assess Neumora Therapeutics Inc. potentialWeekly Profit Report & Free Daily Entry Point Trade Alerts - Newser

Aug 27, 2025
pulisher
Aug 27, 2025

Exit strategy if you’re trapped in Neumora Therapeutics Inc.Quarterly Trade Review & Breakout Confirmation Trade Signals - Newser

Aug 27, 2025
pulisher
Aug 27, 2025

Can momentum traders help lift Neumora Therapeutics Inc.Market Trend Report & Fast Entry Momentum Alerts - Newser

Aug 27, 2025
pulisher
Aug 27, 2025

Short interest data insights for Neumora Therapeutics Inc.Market Performance Summary & Weekly High Conviction Ideas - Newser

Aug 27, 2025
pulisher
Aug 27, 2025

What MACD signals say about Neumora Therapeutics Inc.2025 Fundamental Recap & Fast Gain Swing Trade Alerts - Newser

Aug 27, 2025
pulisher
Aug 27, 2025

Can Neumora Therapeutics Inc. recover in the next quarter2025 Top Gainers & AI Enhanced Execution Alerts - Newser

Aug 27, 2025
pulisher
Aug 27, 2025

T. Rowe Price Investment Management Inc. Sells 2,899,770 Shares of Neumora Therapeutics, Inc. $NMRA - MarketBeat

Aug 27, 2025
pulisher
Aug 26, 2025

What the charts say about Neumora Therapeutics Inc. todayMarket Activity Recap & Free Daily Entry Point Trade Alerts - Newser

Aug 26, 2025
pulisher
Aug 26, 2025

Key metrics from Neumora Therapeutics Inc.’s quarterly dataMarket Movers & Real-Time Chart Breakout Alerts - Newser

Aug 26, 2025
pulisher
Aug 26, 2025

Neumora Therapeutics Inc. stock volume spike explainedJuly 2025 News Drivers & Low Drawdown Momentum Trade Ideas - Newser

Aug 26, 2025
pulisher
Aug 26, 2025

Technical analysis overview for Neumora Therapeutics Inc. stock - Newser

Aug 26, 2025
pulisher
Aug 26, 2025

Relative strength of Neumora Therapeutics Inc. in sector analysisEarnings Risk Summary & Real-Time Volume Spike Alerts - Newser

Aug 26, 2025
pulisher
Aug 26, 2025

Real time alert setup for Neumora Therapeutics Inc. performance2025 Market Sentiment & Fast Entry High Yield Tips - Newser

Aug 26, 2025
pulisher
Aug 25, 2025

How to build a dashboard for Neumora Therapeutics Inc. stockTrade Performance Summary & AI Optimized Trade Strategies - Newser

Aug 25, 2025
pulisher
Aug 25, 2025

Short interest data insights for Neumora Therapeutics IncJuly 2025 Earnings & Fast Entry and Exit Trade Plans - Newser

Aug 25, 2025
pulisher
Aug 25, 2025

Published on: 2025-08-25 00:48:16 - Newser

Aug 25, 2025
pulisher
Aug 24, 2025

Best data tools to analyze Neumora Therapeutics Inc. stockQuarterly Earnings Summary & Verified Momentum Stock Ideas - Newser

Aug 24, 2025
pulisher
Aug 24, 2025

How institutional ownership impacts Neumora Therapeutics Inc. stockEarnings Overview Report & Safe Investment Capital Preservation Plans - Newser

Aug 24, 2025
pulisher
Aug 24, 2025

What data driven models say about Neumora Therapeutics Inc.’s futureJuly 2025 Action & Pattern Based Trade Signal System - Newser

Aug 24, 2025
pulisher
Aug 24, 2025

Signal strength of Neumora Therapeutics Inc. stock in tech scannersMarket Sentiment Report & Daily Momentum Trading Reports - Newser

Aug 24, 2025
pulisher
Aug 24, 2025

Trading Recap: Can Neumora Therapeutics Inc. sustain its profitabilityDividend Hike & Daily Oversold Stock Bounce Ideas - theviewers.co.kr

Aug 24, 2025
pulisher
Aug 23, 2025

Understanding Neumora Therapeutics Inc.’s price movementWeekly Investment Report & Entry Point Strategy Guides - Newser

Aug 23, 2025
pulisher
Aug 23, 2025

Will Neumora Therapeutics Inc. rebound enough to break even2025 Technical Overview & Weekly High Return Stock Forecasts - Newser

Aug 23, 2025
pulisher
Aug 22, 2025

Technical Charts Suggest Momentum Shift in Neumora Therapeutics Inc.July 2025 EndofMonth & Fast Gain Swing Alerts - beatles.ru

Aug 22, 2025
pulisher
Aug 22, 2025

Will Neumora Therapeutics Inc. stock go up in YEARJuly 2025 Movers & AI Powered Trade Plan Recommendations - sundaytimes.kr

Aug 22, 2025
pulisher
Aug 22, 2025

Live Scanner Shows Breakout on Neumora Therapeutics Inc.July 2025 Highlights & Safe Entry Zone Identification - 더경남뉴스

Aug 22, 2025
pulisher
Aug 22, 2025

Can Neumora Therapeutics Inc. Outperform Peers After Recent PullbackJuly 2025 Price Swings & Fast Moving Stock Trade Plans - beatles.ru

Aug 22, 2025
pulisher
Aug 21, 2025

Volume spikes in Neumora Therapeutics Inc. stock – what they meanWeekly Trading Summary & Stock Portfolio Risk Management - Newser

Aug 21, 2025
pulisher
Aug 21, 2025

Is Neumora Therapeutics Inc. on track to beat earningsPortfolio Performance Summary & Weekly Setup with ROI Potential - theviewers.co.kr

Aug 21, 2025
pulisher
Aug 21, 2025

Neumora Therapeutics Initiates Phase 1 Study for Schizophrenia Drug NMRA-861 - MSN

Aug 21, 2025
pulisher
Aug 21, 2025

Is now the right time to enter Neumora Therapeutics Inc.July 2025 Chart Watch & Detailed Earnings Play Alerts - theviewers.co.kr

Aug 21, 2025
pulisher
Aug 21, 2025

Why Neumora Therapeutics Inc. stock attracts strong analyst attention2025 Fundamental Recap & Weekly Setup with ROI Potential - beatles.ru

Aug 21, 2025

Neumora Therapeutics Inc (NMRA) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$24.78
price up icon 0.98%
$84.84
price up icon 1.00%
$24.80
price down icon 8.06%
$103.01
price down icon 1.70%
$134.53
price up icon 1.79%
biotechnology ONC
$300.14
price down icon 2.84%
자본화:     |  볼륨(24시간):